Now showing items 1-8 of 1

    Adherence (1)
    Cost sharing (1)
    Diffuse large B-cell lymphoma (1)
    Health sciences (1)
    Ibrutinib (1)
    Out-of pocket costs (1)
    Persistence (1)
    Pharmaceutical sciences (1)